These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31498866)

  • 1. Metadherin-PRMT5 complex enhances the metastasis of hepatocellular carcinoma through the WNT-β-catenin signaling pathway.
    Zhu K; Peng Y; Hu J; Zhan H; Yang L; Gao Q; Jia H; Luo R; Dai Z; Tang Z; Fan J; Zhou J
    Carcinogenesis; 2020 Apr; 41(2):130-138. PubMed ID: 31498866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. USP25 promotes hepatocellular carcinoma progression by interacting with TRIM21 via the Wnt/β-catenin signaling pathway.
    Liu Y; Ma J; Lu S; He P; Dong W
    Chin Med J (Engl); 2023 Sep; 136(18):2229-2242. PubMed ID: 37439386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combined bioinformatics and experimental approach identifies RMI2 as a Wnt/β-catenin signaling target gene related to hepatocellular carcinoma.
    Tsai HW; Cheng SW; Chen CC; Chen IW; Ho CL
    BMC Cancer; 2023 Oct; 23(1):1025. PubMed ID: 37875822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMYD4 monomethylates PRMT5 and forms a positive feedback loop to promote hepatocellular carcinoma progression.
    Zhou Z; Chen Z; Zhou Q; Meng S; Shi J; Mui S; Jiang H; Lin J; He G; Li W; Zhang J; Wang J; He C; Yan Y; Xiao Z
    Cancer Sci; 2024 May; 115(5):1587-1601. PubMed ID: 38438251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TC2N Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Targeting the Wnt/β-Catenin Signaling Pathway.
    Lou YX; Gu J; Zhu L; Sun SQ; Hao XL; Chen JP; Han F; Wang DD; Jiang X; Liu JY
    Lab Invest; 2023 Dec; 103(12):100260. PubMed ID: 37839635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ILKAP Promotes the Metastasis of Hepatocellular Carcinoma Cells by Inhibiting β-Catenin Degradation and Enhancing the WNT Signaling Pathway.
    Zhang R; Yuan J; Liu S; Torraca V; Liao Z; Wu Y; Tan H; Yao X; Hou X; Lyu H; Xiao S; Guo D; Ali DW; Michalak M; Chen XZ; Zhou C; Tang J
    Adv Biol (Weinh); 2024 May; 8(5):e2300117. PubMed ID: 38379270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metadherin promotes stem cell phenotypes and correlated with immune infiltration in hepatocellular carcinoma.
    Wang YY; Shen MM; Gao J
    World J Gastroenterol; 2024 Feb; 30(8):901-918. PubMed ID: 38516242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metadherin-driven promotion of cancer stem cell phenotypes and its effect on immunity in hepatocellular carcinoma.
    Todorović N; Amedei A
    World J Gastroenterol; 2024 May; 30(20):2624-2628. PubMed ID: 38855151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA 5-methylcytosine writer NSUN5 promotes hepatocellular carcinoma cell proliferation via a ZBED3-dependent mechanism.
    Gu X; Li P; Gao X; Ru Y; Xue C; Zhang S; Liu Y; Hu X
    Oncogene; 2024 Feb; 43(9):624-635. PubMed ID: 38182896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Targeting of Metadherin Suppresses Colorectal and Lung Cancer Progression and Metastasis.
    Shen M; Xie S; Rowicki M; Michel S; Wei Y; Hang X; Wan L; Lu X; Yuan M; Jin JF; Jaschinski F; Zhou T; Klar R; Kang Y
    Cancer Res; 2021 Feb; 81(4):1014-1025. PubMed ID: 33239430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metadherin contribute to BCR signaling in chronic lymphocytic leukemia.
    Li PP; Yao QM; Zhou H; Feng LL; Ge XL; Lv X; Chen N; Lu K; Wang X
    Int J Clin Exp Pathol; 2014; 7(4):1588-94. PubMed ID: 24817955
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Wang SS; Zhai GQ; Chen G; Huang ZG; Zhang Y; Zhang LJ; Dang YW; Li SH; Yan HB
    Cancer Biother Radiopharm; 2023 Nov; 38(9):650-662. PubMed ID: 35704039
    [No Abstract]   [Full Text] [Related]  

  • 13. USP7 promotes cervical cancer progression by stabilizing MTDH expression through deubiquitination.
    Wang N; Xu J; Wang Y; Zhang X; Zhang H
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):196. PubMed ID: 38625581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRMT5 Mediated HIF1α Signaling and Ras-Related Nuclear Protein as Promising Biomarker in Hepatocellular Carcinoma.
    Abumustafa W; Castven D; Sharif-Askari FS; Abi Zamer B; Hamad M; Marquardt JU; Muhammad JS
    Biology (Basel); 2024 Mar; 13(4):. PubMed ID: 38666828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CircMMP2(6,7) Cooperates with β-Catenin and PRMT5 to Disrupt Bone Homeostasis and Promote Breast Cancer Bone Metastasis.
    Xu Y; Li X; Zhang S; Tang M; Yu R; Liao X; Li Z; Li M; Chen S; Qian W; Song L; Ke Z; Li J
    Cancer Res; 2024 Jan; 84(2):328-343. PubMed ID: 37963200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial transcriptomics unravels palmitoylation and zonation-dependent gene regulation by AEG-1 in mouse liver.
    Saverino A; Qu X; Mendoza RG; Raha S; Manna D; Ermi AG; Subler MA; Windle JJ; Liu J; Sarkar D
    J Biol Chem; 2024 Jun; 300(6):107322. PubMed ID: 38677511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FZD6 Promotes Melanoma Cell Invasion but Not Proliferation by Regulating Canonical Wnt Signaling and Epithelial‒Mesenchymal Transition.
    Dong B; Simonson L; Vold S; Oldham E; Barten L; Ahmad N; Chang H
    J Invest Dermatol; 2023 Apr; 143(4):621-629.e6. PubMed ID: 36368445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction for: MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition.
    He A; He S; Huang C; Chen Z; Wu Y; Gong Y; Li X; Zhou L
    Aging (Albany NY); 2024 Apr; 16(7):6629-6630. PubMed ID: 38647434
    [No Abstract]   [Full Text] [Related]  

  • 19. PRMT5 confers lipid metabolism reprogramming, tumour growth and metastasis depending on the SIRT7-mediated desuccinylation of PRMT5 K387 in tumours.
    Yuan HF; Zhao M; Zhao LN; Yun HL; Yang G; Geng Y; Wang YF; Zheng W; Yuan Y; Song TQ; Niu JQ; Zhang XD
    Acta Pharmacol Sin; 2022 Sep; 43(9):2373-2385. PubMed ID: 35046516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of SND1-MTDH Interaction by a High Affinity Peptide Results in SND1 Degradation and Cytotoxicity to Breast Cancer Cells
    Li P; He Y; Chen T; Choy KY; Chow TS; Wong ILK; Yang X; Sun W; Su X; Chan TH; Chow LMC
    Mol Cancer Ther; 2021 Jan; 20(1):76-84. PubMed ID: 33268570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.